Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 147

    1.

    Smoking is associated with progression of diabetic nephropathy.

    Sawicki PT, Didjurgeit U, Mühlhauser I, Bender R, Heinemann L, Berger M.

    Diabetes Care. 1994 Feb;17(2):126-31.PMID: 8137682 [PubMed - indexed for MEDLINE]Related articles

    2.

    Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus.

    Gambaro G, Bax G, Fusaro M, Normanno M, Manani SM, Zanella M, Dangelo A, Fedele D, Favaro S.

    Diabetes Nutr Metab. 2001 Dec;14(6):337-42.PMID: 11853366 [PubMed - indexed for MEDLINE]Related articles

    3.

    Smoking and progression of diabetic nephropathy in type 1 diabetes.

    Hovind P, Rossing P, Tarnow L, Parving HH.

    Diabetes Care. 2003 Mar;26(3):911-6.PMID: 12610058 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.

    Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R.

    Arch Intern Med. 1998 May 11;158(9):998-1004.PMID: 9588433 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes.

    Chuahirun T, Simoni J, Hudson C, Seipel T, Khanna A, Harrist RB, Wesson DE.

    Am J Med Sci. 2004 Feb;327(2):57-67.PMID: 14770020 [PubMed - indexed for MEDLINE]Related articles

    6.

    Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes.

    Chuahirun T, Khanna A, Kimball K, Wesson DE.

    Am J Kidney Dis. 2003 Jan;41(1):13-21.PMID: 12500217 [PubMed - indexed for MEDLINE]Related articles

    7.

    Permissive role of hypertension in the development of proteinuria and progression of renal disease in insulin-dependent diabetic patients.

    Earle KA, Morocutti A, Viberti G.

    J Hypertens. 1997 Feb;15(2):191-6.PMID: 9469795 [PubMed - indexed for MEDLINE]Related articles

    8.

    Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.

    Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Pagano G, Cavallo Perin P; Casale Monferrato Study.

    Diabetes Care. 2003 Jul;26(7):2150-5.PMID: 12832328 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.

    Crepaldi G, Carta Q, Deferrari G, Mangili R, Navalesi R, Santeusanio F, Spalluto A, Vanasia A, Villa GM, Nosadini R.

    Diabetes Care. 1998 Jan;21(1):104-10.PMID: 9538979 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Continued smoking exacerbates but cessation ameliorates progression of early type 2 diabetic nephropathy.

    Phisitkul K, Hegazy K, Chuahirun T, Hudson C, Simoni J, Rajab H, Wesson DE.

    Am J Med Sci. 2008 Apr;335(4):284-91.PMID: 18414067 [PubMed - indexed for MEDLINE]Related articles

    12.

    The 10-year incidence of renal insufficiency in people with type 1 diabetes.

    Klein R, Klein BE, Moss SE, Cruickshanks KJ, Brazy PC.

    Diabetes Care. 1999 May;22(5):743-51.PMID: 10332675 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition.

    Chuahirun T, Wesson DE.

    Am J Kidney Dis. 2002 Feb;39(2):376-82.PMID: 11840380 [PubMed - indexed for MEDLINE]Related articles

    14.

    Value of blood pressure self-monitoring as a predictor of progression of diabetic nephropathy.

    Rave K, Bender R, Heise T, Sawicki PT.

    J Hypertens. 1999 May;17(5):597-601.PMID: 10403602 [PubMed - indexed for MEDLINE]Related articles

    15.

    Influence of cigarette-smoking on the progression of clinical diabetic nephropathy in type 2 diabetic patients.

    Biesenbach G, Grafinger P, Janko O, Zazgornik J.

    Clin Nephrol. 1997 Sep;48(3):146-50.PMID: 9342485 [PubMed - indexed for MEDLINE]Related articles

    16.

    Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.

    Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G.

    Am J Kidney Dis. 2000 Jun;35(6):1155-65.PMID: 10845831 [PubMed - indexed for MEDLINE]Related articles

    17.

    Renal involvement in type 1 (IDDM) diabetes in Spain. ESTUDIO DIAMANTE.

    [No authors listed]

    Diabetes Res Clin Pract. 1997 Nov;38(2):129-37.PMID: 9483377 [PubMed - indexed for MEDLINE]Related articles

    18.

    Progression of diabetic nephropathy in normotensive type 1 diabetic patients.

    Jacobsen P, Rossing K, Tarnow L, Rossing P, Mallet C, Poirier O, Cambien F, Parving HH.

    Kidney Int Suppl. 1999 Jul;71:S101-5.PMID: 10412749 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effects of smoking on 24-h ambulatory blood pressure and autonomic function in normoalbuminuric insulin-dependent diabetes mellitus patients.

    Poulsen PL, Ebbehøj E, Hansen KW, Mogensen CE.

    Am J Hypertens. 1998 Sep;11(9):1093-9.PMID: 9752895 [PubMed - indexed for MEDLINE]Related articles

    20.

    Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control.

    Alaveras AE, Thomas SM, Sagriotis A, Viberti GC.

    Nephrol Dial Transplant. 1997;12 Suppl 2:71-4.PMID: 9269705 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data